Barrington Research Reiterates Kensey Nash Outperform, $33 PT

Barrington Research reiterated its Kensey Nash

Outperform rating and $33 price target in a research report published today. In the report, Barrington Research states, "Following Q1/12 results, we are reiterating our OUTPERFORM rating and $33 price target for KNSY. We believe that between its product innovation and competitive advantages in developing next generation biomaterial technology, KNSY will continue to grow its top and bottom line for the foreseeable future." Shares of Kensey Nash were trading at $25.45 at the time of posting, up 0.20% from Thursday's market close.